“…Phage lysins have attracted considerable interest as novel antimicrobials against gram-positive bacteria and have been used to control a wide range of pathogens such as group A streptococci (9), Streptococcus pneumoniae (4), Bacillus anthracis (13), and Enterococcus faecalis (15). In the 1950s, a lytic enzyme, "virolysin," obtained from phage lysates after phage K infection of Staphylococcus aureus strain K1, was reported (12). However, virolysin was only active against dead and not live cells (12).…”